ResMed
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ResMed generated cash of $1,401,260,000, which is more than the previous year. Cash used in financing activities reached the amount of -$1,119,287,000 last year. Net change in cash is therefore $10,470,000.
Cash Flow
| 2015 | 383.18M | -143.07M | -255.79M |
|---|---|---|---|
| 2016 | 547.93M | -1.12B | 612.58M |
| 2017 | 414.05M | -81.89M | -262.86M |
| 2018 | 505.02M | -101.82M | -1.02B |
| 2019 | 459.05M | -1.07B | 580.64M |
| 2020 | 802.25M | -179.86M | -317.28M |
| 2021 | 736.71M | -158.46M | -764.63M |
| 2022 | 351.14M | -229.91M | -128.36M |
| 2023 | 693.29M | -1.15B | 422.87M |
| 2024 | 1.40B | -269.78M | -1.11B |
RMD Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 227.89M | 273.71M | 295.27M | 463.15M | 147.12M | 188.70M | 821.93M | 731.43M | 717.24M | 905.73M |
Operating activities | ||||||||||
Net income | 1.02B | 897.55M | 779.43M | 474.50M | 621.67M | 404.59M | 315.58M | 342.28M | 352.40M | 352.88M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 216.20M | 197.56M | 193.84M | 191.51M | 181.37M | 150.79M | 119.96M | 112.15M | 86.84M | 73.05M |
Stock-based compensation expense | 80.18M | 71.14M | 65.25M | 63.92M | 57.55M | 52.07M | 48.41M | 45.92M | 46.40M | 47.85M |
| Deferred income tax benefit | 80.18M | 71.14M | 65.25M | 63.92M | 57.55M | 52.07M | 48.41M | 45.92M | 46.40M | 47.85M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -106.51M | 19.34M | -129.19M | 54.38M | -18.01M | -32.35M | -63.60M | -27.30M | -28.25M |
Inventories | 172.20M | -248.83M | -311.68M | -21.95M | -69.88M | -84.18M | 1.49M | -41.59M | 30.49M | -99.52M |
Accounts payable | 0 | 31.34M | -247.63M | 210.70M | -23.42M | -27.27M | 200.65M | 34.57M | 46.38M | 85.81M |
Cash generated by operating activities | 1.40B | 693.29M | 351.14M | 736.71M | 802.25M | 459.05M | 505.02M | 414.05M | 547.93M | 383.18M |
Investing activities | ||||||||||
Purchases Of Investments | -22.46M | -32.22M | -37.9M | -21.78M | -46.01M | -46.98M | -29.46M | -6.46M | -16.52M | -42.65M |
Investments In Property Plant And Equipment | -99.46M | -134M | -156.03M | -116.82M | -105.93M | -77.34M | -71.45M | -71.47M | -67.82M | -71.94M |
Acquisitions Net | -133.46M | -1.01B | -42.78M | -39.06M | -27.91M | -951.38M | -902K | -7.27M | -1.04B | -28.47M |
Cash generated by investing activities | -269.78M | -1.15B | -229.91M | -158.46M | -179.86M | -1.07B | -101.82M | -81.89M | -1.12B | -143.07M |
Financing activities | ||||||||||
Common Stock Issued | 53.09M | 49.14M | 47.38M | 37.79M | 48.18M | 36.72M | 23.33M | 30.16M | 27.69M | 38.80M |
Payments for dividends | -282.32M | -258.27M | -245.34M | -226.71M | -225.09M | -211.71M | -199.49M | -186.34M | -168.13M | -157.26M |
Repurchases of common stock | -150.01M | 0 | 0 | -50.20M | 1.19B | -22.84M | -53.80M | 0 | -102.05M | -160.3M |
Repayments of term debt | -730M | 665M | 122M | -522M | -1.28B | 807.48M | -1.14B | -95M | -283.69M | -1.53M |
Cash used in financing activities | -1.11B | 422.87M | -128.36M | -764.63M | -317.28M | 580.64M | -1.02B | -262.86M | 612.58M | -255.79M |
Net Change In Cash | 10.47M | -45.81M | -21.56M | -167.87M | 316.02M | -41.57M | -633.23M | 90.50M | 14.18M | -188.48M |
Cash at end of period | 238.36M | 227.89M | 273.71M | 295.27M | 463.15M | 147.12M | 188.70M | 821.93M | 731.43M | 717.24M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |